Lovaza and Gas gangrene - a phase IV clinical study of FDA data

Summary:

Gas gangrene is reported only by a few people who take Lovaza.

The phase IV clinical study analyzes which people take Lovaza and have Gas gangrene. It is created by eHealthMe based on reports of 16,224 people who have side effects while taking Lovaza from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 27, 2023

16,224 people reported to have side effects when taking Lovaza.
Among them, 3 people (0.02%) have Gas gangrene.

What is Lovaza?

Lovaza has active ingredients of omega-3-acid ethyl esters. It is often used in high blood cholesterol. eHealthMe is studying from 16,913 Lovaza users for its effectiveness, alternative drugs and more.

What is Gas gangrene?

Gas gangrene (bacterial infection that produces gas within tissues) is found to be associated with 360 drugs and 231 conditions by eHealthMe.

Number of Lovaza and Gas gangrene reports submitted per year:

Gender of people who have Gas gangrene when taking Lovaza *:

female: 0.0 %
male: 100 %

Age of people who have Gas gangrene when taking Lovaza *:

Common drugs people take besides Lovaza *:

Common conditions people have *:

Wheezing (a high-pitched whistling sound made while you breath): 3 people, 100.00%
Type 2 Diabetes: 3 people, 100.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 100.00%
Pain: 3 people, 100.00%
Nausea (feeling of having an urge to vomit): 3 people, 100.00%
Breathing Difficulty: 3 people, 100.00%
High Blood Pressure: 2 people, 66.67%

* Approximation only. Some reports may have incomplete information.

Do you take Lovaza and have Gas gangrene?

Check whether Gas gangrene is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Gas gangrene and when was it recovered:

Gas gangrene in Lovaza

Expand to all the drugs that have ingredients of omega-3-acid ethyl esters:

Gas gangrene and drugs with ingredients of omega-3-acid ethyl esters

Alternative drugs to, pros and cons of Lovaza:

Lovaza (16,913 reports)

Common Lovaza side effects:

Skin blushing/flushing (a sudden reddening of the face, neck): 1,063 reports
Fatigue (feeling of tiredness): 1,045 reports
Pain: 929 reports
Dizziness: 873 reports
Diarrhea: 862 reports
Drug ineffective: 841 reports
Headache (pain in head): 826 reports
Rashes (redness): 800 reports

Browse all side effects of Lovaza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Gas gangrene treatments and more:

Gas gangrene (481 reports)

COVID vaccines that are related to Gas gangrene:

Common drugs associated with Gas gangrene:

Invokana: 124 reports

All the drugs that are associated with Gas gangrene:

Gas gangrene (360 drugs)

All the conditions that are associated with Gas gangrene:

Gas gangrene (231 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on omega-3-acid ethyl esters (the active ingredients of Lovaza) and Lovaza (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.